arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Gevo, Inc.

GEVO
$1.46 ▼ -0.10 (-6.43%) at close
Materials ·Industrial Organic Chemicals ·USIndustrial Organic Chemicals
71 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
37
Health
Weak
Bearish
auto_awesome

Analytical Summary

Gevo, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $346.1M
Dividend Yield
Revenue Growth 7.1%
Op. Margin -369.3%
ROIC -30.8%
FCF / Share $-0.09
Trailing P/E
Price / Book 1.3x
FCF Yield
Debt / Equity 0.61
info Valuation on last close. End-of-day price, Sep 23, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$46.50M
↑ +7.1%
Net Income Profit after all expenses
$-176.94M
↓ -715.5%
Operating Margin Operating profit as % of sales
-369.3%
↓ -3137.8% 13th
FCF / Share Free cash flow per share
$-0.09
↑ +30.9%
Long-Term Debt Long-term obligations
$167.24M
— +0.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
10
Returns
36
Financial Health
52
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 21 years · 71 quarters